Penumbra saw the highest growth of 2.99% in patent filings in May and 0.99% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.49% and grants by 0.99%. GlobalData’s DataBook provides a comprehensive analysis of Penumbra’s patent filings and grants. Buy the databook here.
Penumbra has been focused on protecting inventions in United States(US) with seven publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 80% filings and 100% grants. The United States(US), and European Patent Office(EPO) patent Office are among the top ten patent offices where Penumbra is filings its patents. Among the top granted patent authorities, Penumbra has 100% of its grants in United States(US).
Olympus could be the strongest competitor for Penumbra
Patents related to healthtech and mobile gaming lead Penumbra's portfolio
Penumbra has the highest number of patents in healthtech followed by, mobile gaming and wearable tech. For healthtech no patents were filed and 25% of patents were granted in Q2 2024.
General surgery devices related patents lead Penumbra portfolio followed by aspiration catheters, and ophthalmic devices
Penumbra has highest number of patents in general surgery devices followed by aspiration catheters, ophthalmic devices, consumer applications, and augmented reality. For general surgery devices, nearly 80% of patents were filed and 29% of patents were granted in Q2 2024.
For comprehensive analysis of Penumbra's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.